In this issue:
External validation of SUNTRAC in solid organ transplant recipients
Cutaneous involvement in catastrophic APS
Apremilast for recalcitrant cutaneous dermatomyositis
Dermatological follow-up vs. ED return in HS after initial ED visit
Topical brepocitinib for mild-to-moderate AD
Rifampicin-moxifloxacin-metronidazole for severe HS
Clinical outcomes of high-risk cutaneous SCCs treated with Mohs surgery
Treatment patterns and outcomes of chronic urticaria during pregnancy
Upadacitinib for AD
Intralesional MMR vs. PPD for palmoplantar/periungual warts
Please login below to download this issue (PDF)